Nuvalent is a biotech company creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Register for Details

For more details on financing and valuation for Nuvalent, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Nuvalent's ticker symbol?


What is Nuvalent's stock price?

43.59 as of 9/22/23

Learn more about Nuvalent

Forge green plus iconForge green minus icon

When was Nuvalent founded?

Nuvalent was founded in 2017.
Updated on: Jun 12, 2022